Patent 9421329 was granted and assigned to Tandem Diabetes Care on August, 2016 by the United States Patent and Trademark Office.
Device and method embodiments are described which are capable of detecting and alerting a user of an infusion device to a hindrance in the ability to deliver measured quantities of fluids. In some cases, the devices and method embodiments for such occlusion detection do not require significant modification of an infusion device and can be carried out with a minimum of additional components.